rss
10-11-2014, 12:40 AM
Orsiro Stent with Hybrid Drug-Eluting Coating **w Available in France
http://cdn.medgadget.com/wp-content/uploads/2014/10/Orsiro-stent.png
BIOTRONIK is releasing the Orsiro, the world’s first hybrid drug-eluting stent, in the French market. The device features a passive proBIO coating that isolates the stent’s metal from the vessel walls, and an active BIOlute biocompatible coating that releases a limus to prevent reste**sis.
The combination coating sits over the company’s PRO-Kinetic Energy stent architecture which BIOTRONIK touts as having thin struts and excellent deliverability.
“We are happy to an**unce that the Orsiro hybrid DES, one of three stent systems in the BIOTRONIK Masterpieces portfolio along with the PRO-Kinetic Energy bare metal stent and the PK Papyrus covered stent, will **w be available to yet a**ther patient population that needs it,” Dr. Alexander Uhl, Vice President of Marketing, BIOTRONIK Vascular Intervention, said in a statement. “Physicians rely on top performing tools for each and every procedure. We see the launch of Orsiro in France as a crucial step towards giving an even greater number of physicians worldwide the chance to work with a tool that we consider a Masterpiece.”
Product page: Orsiro Hybrid Drug Eluting Stent… (http://www.biotronik.com/wps/wcm/connect/en_orsiro/biotronik/home)
Results of the BIOSCIENCE trial comparing Orsiro with Xience Prime stent in Lancet: Revisiting the BIOSCIENCE of drug-eluting stent tech**logy… (http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61415-X/fulltext)
Press release: BIOTRONIK to Offer New Treatment Options in France with Release of Orsiro Drug-Eluting Stent… (http://www.biotronik.com/wps/wcm/connect/int_web/biotronik/newsroom/press_releases?p=http://www.biotronik.com/wps/wcm/connect/int_web/biotronik/newsroom/press_releases/2014/pr_orsiro_france_en&pw=770&pt=)
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=O6ywSDlA010:LD0Na4YyJ0U:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=O6ywSDlA010:LD0Na4YyJ0U:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=O6ywSDlA010:LD0Na4YyJ0U:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=O6ywSDlA010:LD0Na4YyJ0U:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/O6ywSDlA010
http://cdn.medgadget.com/wp-content/uploads/2014/10/Orsiro-stent.png
BIOTRONIK is releasing the Orsiro, the world’s first hybrid drug-eluting stent, in the French market. The device features a passive proBIO coating that isolates the stent’s metal from the vessel walls, and an active BIOlute biocompatible coating that releases a limus to prevent reste**sis.
The combination coating sits over the company’s PRO-Kinetic Energy stent architecture which BIOTRONIK touts as having thin struts and excellent deliverability.
“We are happy to an**unce that the Orsiro hybrid DES, one of three stent systems in the BIOTRONIK Masterpieces portfolio along with the PRO-Kinetic Energy bare metal stent and the PK Papyrus covered stent, will **w be available to yet a**ther patient population that needs it,” Dr. Alexander Uhl, Vice President of Marketing, BIOTRONIK Vascular Intervention, said in a statement. “Physicians rely on top performing tools for each and every procedure. We see the launch of Orsiro in France as a crucial step towards giving an even greater number of physicians worldwide the chance to work with a tool that we consider a Masterpiece.”
Product page: Orsiro Hybrid Drug Eluting Stent… (http://www.biotronik.com/wps/wcm/connect/en_orsiro/biotronik/home)
Results of the BIOSCIENCE trial comparing Orsiro with Xience Prime stent in Lancet: Revisiting the BIOSCIENCE of drug-eluting stent tech**logy… (http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61415-X/fulltext)
Press release: BIOTRONIK to Offer New Treatment Options in France with Release of Orsiro Drug-Eluting Stent… (http://www.biotronik.com/wps/wcm/connect/int_web/biotronik/newsroom/press_releases?p=http://www.biotronik.com/wps/wcm/connect/int_web/biotronik/newsroom/press_releases/2014/pr_orsiro_france_en&pw=770&pt=)
http://feeds.feedburner.com/~ff/Medgadget?d=yIl2AUoC8zA (http://feeds.feedburner.com/~ff/Medgadget?a=O6ywSDlA010:LD0Na4YyJ0U:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/Medgadget?d=qj6IDK7rITs (http://feeds.feedburner.com/~ff/Medgadget?a=O6ywSDlA010:LD0Na4YyJ0U:qj6IDK7rITs) http://feeds.feedburner.com/~ff/Medgadget?i=O6ywSDlA010:LD0Na4YyJ0U:gIN9vFwOqvQ (http://feeds.feedburner.com/~ff/Medgadget?a=O6ywSDlA010:LD0Na4YyJ0U:gIN9vFwOqvQ)
http://feeds.feedburner.com/~r/Medgadget/~4/O6ywSDlA010